AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $2.16M invested in Akari Therapeutics in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$300K
2
+$150K
3
+$32K

Top Sellers

1
-$62K
2
-$33K
3
-$31K
4
Millennium Management
Millennium Management
New York
-$25K
5
Renaissance Technologies
Renaissance Technologies
New York
-$7.58K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1M
2
$678K
3
$150K
4
$135K
5
$90K
6
$45K
7
$32K
8
$18K
9
$8K
10
$4K
11
$2K
12
–
13
–
14
–
15
–
16
–